Vyant Bio, Inc. is a biotechnology company, which engages in drug discovery for complex neurodevelopmental and neurodegenerative disorders. The company is headquartered in Cherry Hill, New Jersey and currently employs 8 full-time employees. The company went IPO on 2013-04-10. The firm is seeking to obtain its shareholders’ approval for the voluntary liquidation and dissolution of the Company, pursuant to a plan of liquidation and dissolution.

Industry: Services-Medical Laboratories Peers: Aptevo Therapeutics Inc Old Ayala, Inc bioAffinity Technologies Inc Cabaletta Bio Inc Innovation Pharmaceuticals Inc. Bio Green Med Solution Inc YIELD10 BIOSCIENCE, INC. NexImmune, Inc. Sigilon Therapeutics, Inc.